| dc.contributor.author |
Deen, K.I. |
en_US |
| dc.date.accessioned |
2014-10-29T09:14:50Z |
|
| dc.date.available |
2014-10-29T09:14:50Z |
|
| dc.date.issued |
1996 |
en_US |
| dc.identifier.citation |
European Journal of Surgery. 1996; 162(5): pp.403-405 |
en_US |
| dc.identifier.issn |
1102-4151 (Print) |
en_US |
| dc.identifier.uri |
http://repository.kln.ac.lk/handle/123456789/1288 |
|
| dc.description |
Indexed in MEDLINE |
|
| dc.description.abstract |
OBJECTIVE: To assess the efficacy of single, large dose injection sclerotherapy together with oral Daflon 500 mg in the management of isolated strangulated haemorrhoids. DESIGN: Prospective non randomised study. SETTING: Private hospital, Sri Lanka. SUBJECTS: 15 patients (9 men and 6 women, median age 28 years, range 19-54) with isolated strangulated haemorrhoids. MAIN OUTCOMEMEASURES: Resolution of symptoms at 12 weeks, residual haemorrhoids, and side effects of Daflon. RESULTS: 14 patients were evaluated at 12 weeks, and symptoms had resolved completely in 13. In all of these patients, the prolapsed haemorrhoid was restored within the anal canal. The remaining patient developed circumferential prolapsed haemorrhoids which were treated by surgical excision. No side effects of Daflon were reported. CONCLUSION: Single, large dose injection sclerotherapy combined with Daflon 500 mg was beneficial in the short term in patients with isolated strangulated haemorrhoids. |
en_US |
| dc.publisher |
Taylor and Francis |
en_US |
| dc.subject |
Ambulatory Care |
|
| dc.subject |
Combined Modality Therapy |
|
| dc.subject |
Diosmin-administration and dosage |
|
| dc.subject |
Hemorrhoids-therapy |
|
| dc.subject |
Injections, Intralesional |
|
| dc.subject |
Prospective Studies |
|
| dc.subject |
Sclerotherapy-methods |
|
| dc.title |
Outpatient treatment of isolated strangulated haemorrhoids with single dose injection sclerotherapy and oral Daflon |
en_US |
| dc.type |
Article |
en_US |
| dc.identifier.department |
Surgery |
en_US |